Emory University and The Ohio State University Medical Center have formed the Alliance for Predictive and Personalized Health--a partnership aimed at transforming health care into a more patient-centered system that integrates scientific breakthroughs in genomics and molecular biology with advances in communications and information technology.
"The recent explosion of medical knowledge in genomics and molecular biology, along with significant advances in bioinformatics and communications technology, will fundamentally and profoundly transform the future practice of medicine," says Fred Sanfilippo, MD, PhD, CEO of Emory University's Woodruff Health Sciences Center and chairman of Emory Healthcare. "Personalized, predictive health care will provide the best prevention and treatment options for each individual, enabling informed decisions based on unique characteristics and using all available scientific knowledge."
The new partnership between Emory and Ohio State builds on innovative programs in predictive and personalized medicine in Emory's Woodruff Health Sciences Center and Ohio State University Medical Center.
Predictive Health is a major initiative within Emory University's strategic plan. In 2005 Emory and the Georgia Institute of Technology established the Emory/Georgia Tech Predictive Health Institute (http://www.phi.emory.edu), which combines a research core investigating new genetic and protein biomarkers with a Center for Health Discovery and Well-Being--a clinical testing ground and translational research center for optimum predictors of health, disease risk and prognosis.
"The current model of health care is neither economically sustainable nor adequately effective in terms of outcomes, accessibility, quality and safety. We have a tremendous opportunity to leverage existing strengths and programs within our institutions, take advantage of this amazing convergence of scientific and technological discovery, an
|Contact: Holly Korschun|